UCL Business Ltd(@UCL_Business ):Earlier this year, @UCL spinout company Autolus Therapeutics announced that the U.S. Food and Drug Administration (FDA) had granted marketing approval for AUCATZYL® (obecabtagene autoleucel, obe-cel), for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). UCLB has supported Autolus in protecting and licensing the obe-cel technology, enabling it to attract further capital to fund its development. More here: https://t.co/ZXqNNcT9e4 #BioPharm #TechTransfer #Spinouts

UCL Business Ltd

@UCL_Business

UCL Business Ltd (UCLB) is the technology commercialisation company of @ucl | @ucltf fund for UCL academics | member of TenU @TenU_News

Joined July 2012

609 Following 1.6K Followers

UCL Business Ltd@UCL_Business

2024.12.18 10:32

Earlier this year, @UCL spinout company Autolus Therapeutics announced that the U.S. Food and Drug Administration (FDA) had granted marketing approval for AUCATZYL® (obecabtagene autoleucel, obe-cel), for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). UCLB has supported Autolus in protecting and licensing the obe-cel technology, enabling it to attract further capital to fund its development. More here: https://t.co/ZXqNNcT9e4 #BioPharm# #TechTransfer# #Spinouts#